title: Efficacy of rituximab in dermatomyositis and polymyositis refractory to conventional therapy.
abstract: We report one case of dermatomyositis and one of polymyositis refractory to several conventional inmunosupressive therapies, which present a response after treatment with rituximab, enabling steroid dose reduction and a prolonged remission.
authors: Sección de Reumatología, Hospital La Mancha Centro, Alcázar de San Juan, España. simon.sanchez.fernandez@gmail.com
authors: Simón Ángel
authors: SÁ
authors: Sánchez-Fernández
authors: José Antonio
authors: JA
authors: Carrasco Fernández
authors: Luisa Marena
authors: LM
authors: Rojas Vargas
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D003882:Dermatomyositis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008875:Middle Aged; D017285:Polymyositis / Q000188:drug therapy*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab